![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Latest Research Progress: Active Components of Traditional Chinese Medicine as Promising Candidates for Ovarian Cancer Therapy
Xiaoyu Zhang, Xiaocen Wei, Lei Shi, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118811-118811
Closed Access | Times Cited: 3
Xiaoyu Zhang, Xiaocen Wei, Lei Shi, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118811-118811
Closed Access | Times Cited: 3
Showing 3 citing articles:
Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment
Tianyun Wang, Yu L. Lei, Jingwei Sun, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Tianyun Wang, Yu L. Lei, Jingwei Sun, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Network pharmacology-based strategy to reveal the mechanism of pinocembrin against ovarian cancer
Guanghui Wang, Jianxiang Cheng, Meizhen Yao, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Guanghui Wang, Jianxiang Cheng, Meizhen Yao, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Anticancer potential of osthole: targeting gynecological tumors and breast cancer
Ying Han, Zhen‐Gao Sun
Pharmacological Reports (2024)
Closed Access
Ying Han, Zhen‐Gao Sun
Pharmacological Reports (2024)
Closed Access